
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $11.8B | $12.6B | $9.5B | $12.6B | $14B | |
Revenue Growth (YoY) | -1.95% | 6.34% | -24.87% | 33.29% | 10.96% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $266.2M | $323M | $494.3M | $554.9M | $586.4M | |
Other Inc / (Exp) | $20.6M | -$60.4M | -$58.7M | -$91.8M | -$124.3M | |
Operating Expenses | $238.2M | $501.3M | $562.1M | $683.4M | $743.1M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | $105M | $121.3M | $90.8M | $106.6M | $85.3M | |
EBT. Incl. Unusual Items | $395M | $605M | $617.7M | $836.5M | $954.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $117.9M | $145.9M | $128.3M | $212.7M | $232.6M | |
Net Income to Company | $277.1M | $459.1M | $489.3M | $623.8M | $721.8M | |
Minority Interest in Earnings | -$12.7M | -$14.5M | $8.8M | -$18.7M | -$23.4M | |
Net Income to Common Excl Extra Items | $264.4M | $444.6M | $498.1M | $605.2M | $698.4M | |
Basic EPS (Cont. Ops) | $0.41 | $0.70 | $0.77 | $0.93 | $1.08 | |
Diluted EPS (Cont. Ops) | $0.41 | $0.70 | $0.77 | $0.93 | $1.08 | |
Weighted Average Basic Share | $640M | $640M | $640M | $640M | $640M | |
Weighted Average Diluted Share | $640M | $640M | $640M | $640M | $640M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $503.5M | $726.3M | $718.1M | $944.1M | $1B | |
Revenue (Reported) | $11.8B | $12.6B | $9.5B | $12.6B | $14B | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $503.5M | $726.3M | $718.1M | $944.1M | $1B |
Period Ending | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | |
---|---|---|---|---|---|---|
Revenue | $3.2B | $2.7B | $2.7B | $3.3B | $3.2B | |
Revenue Growth (YoY) | -12.87% | -17.84% | 2.01% | 20.08% | -4.06% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $122.8M | $115.1M | $107M | -$98.4M | -$101.9M | |
Other Inc / (Exp) | $54.2M | -$120.8M | -$79.3M | -$11.5M | -$63.5M | |
Operating Expenses | $147.9M | -$208.3M | $30.1M | $5.9M | -$214.6M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $97.2M | -$123.5M | $113.7M | $131.1M | $151.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $44M | $41.5M | $16.6M | $5.8M | $46.4M | |
Net Income to Company | $58.2M | -$167.6M | $97.4M | $109M | $114.2M | |
Minority Interest in Earnings | -$15.6M | -$785.6K | -$23.7M | -$28M | -$34.8M | |
Net Income to Common Excl Extra Items | $37.6M | -$165.8M | $73.4M | $97.3M | $70.7M | |
Basic EPS (Cont. Ops) | $0.06 | -$0.26 | $0.10 | $0.13 | $0.10 | |
Diluted EPS (Cont. Ops) | $0.06 | -$0.26 | $0.10 | $0.13 | $0.10 | |
Weighted Average Basic Share | $640M | $640M | $640M | $640M | $640M | |
Weighted Average Diluted Share | $640M | $640M | $640M | $640M | $640M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $97.2M | -$123.5M | $113.7M | $131.1M | $151.9M | |
Revenue (Reported) | $3.2B | $2.7B | $2.7B | $3.3B | $3.2B | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $97.2M | -$123.5M | $113.7M | $131.1M | $151.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $11.9B | $12.5B | $9.3B | $12.6B | $13.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $267.7M | $319.6M | -- | $555.1M | $580.3M | |
Other Inc / (Exp) | $17.7M | -$54.7M | -$56.9M | -$90.3M | -$121.7M | |
Operating Expenses | $439M | $425.7M | -$20.4M | $685M | $736.1M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | $105.4M | $120.3M | $89.9M | $106.8M | $84.4M | |
EBT. Incl. Unusual Items | $394.1M | $600.3M | $607.9M | $838.4M | $945.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $116.8M | $144.8M | $126.9M | $213M | $230.4M | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -$12.7M | -$14.3M | $8.2M | -$18.7M | -$23.2M | |
Net Income to Common Excl Extra Items | $264.5M | $441.2M | $489.3M | $606.6M | $691.6M | |
Basic EPS (Cont. Ops) | $0.41 | $0.69 | $0.76 | $0.94 | $1.07 | |
Diluted EPS (Cont. Ops) | $0.41 | $0.69 | $0.76 | $0.94 | $1.07 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $503.2M | $720.6M | -- | $946.1M | $1B | |
Revenue (Reported) | $11.9B | $12.5B | $9.3B | $12.6B | $13.9B | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $503.2M | $720.6M | -- | $946.1M | $1B |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.1B | $3.1B | $2.5B | $1.7B | $1.8B | |
Short Term Investments | $32B | -- | $24.2B | $26.6B | $25.5B | |
Accounts Receivable, Net | $2.1B | $396.2M | $526.2M | $547.9M | $582.7M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $252.9M | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $37.1B | $3.6B | $27.4B | $29.1B | $28.2B | |
Property Plant And Equipment | $959.6M | $860.6M | $844.4M | $897.6M | $875.7M | |
Long-Term Investments | $35.6B | $46.1B | $36.8B | $40B | $38.9B | |
Goodwill | $1.5B | $1.4B | $1.5B | $1.5B | $1.3B | |
Other Intangibles | $609.8M | $531.3M | $628.2M | $652.6M | $725.1M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $62B | $58B | $50.6B | $53.9B | $53.3B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $509.6M | $275.6M | $124M | $173.6M | $193.7M | |
Long-Term Debt | $2.2B | -- | $2.3B | $1.8B | $1.6B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $55.5B | $52B | $44.5B | $47.2B | $46.5B | |
Common Stock | $163.4M | $2.9B | $2.7B | $2.8B | $2.6B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $6.3B | $5.9B | $5.9B | $6.5B | $6.6B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $151.3M | $126M | $258.7M | $151.9M | $152.2M | |
Total Equity | $6.5B | $6B | $6.1B | $6.7B | $6.8B | |
Total Liabilities and Equity | $62B | $58B | $50.6B | $53.9B | $53.3B | |
Cash and Short Terms | $34.1B | $3.1B | $26.7B | $28.3B | $27.3B | |
Total Debt | $2.2B | -- | $2.3B | $1.8B | $1.6B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.1B | $3.1B | $2.5B | $1.7B | $1.8B | |
Short Term Investments | $32B | -- | $24.2B | $26.6B | $25.5B | |
Accounts Receivable, Net | $2.1B | $396.2M | $526.2M | $547.9M | $582.7M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $252.9M | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $37.1B | $3.6B | $27.4B | $29.1B | $28.2B | |
Property Plant And Equipment | $959.6M | $860.6M | $844.4M | $897.6M | $875.7M | |
Long-Term Investments | $35.6B | $46.1B | $36.8B | $40B | $38.9B | |
Goodwill | $1.5B | $1.4B | $1.5B | $1.5B | $1.3B | |
Other Intangibles | $609.8M | $531.3M | $628.2M | $652.6M | $725.1M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $62B | $58B | $50.6B | $53.9B | $53.3B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $509.6M | $275.6M | $124M | $173.6M | $193.7M | |
Long-Term Debt | $2.2B | -- | $2.3B | $1.8B | $1.6B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $55.5B | $52B | $44.5B | $47.2B | $46.5B | |
Common Stock | $163.4M | $2.9B | $2.7B | $2.8B | $2.6B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $151.3M | $126M | $258.7M | $151.9M | $152.2M | |
Total Equity | $6.5B | $6B | $6.1B | $6.7B | $6.8B | |
Total Liabilities and Equity | $62B | $58B | $50.6B | $53.9B | $53.3B | |
Cash and Short Terms | $34.1B | $3.1B | $26.7B | $28.3B | $27.3B | |
Total Debt | $2.2B | -- | $2.3B | $1.8B | $1.6B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $277.1M | $459.1M | $489.3M | $623.8M | $721.8M | |
Depreciation & Amoritzation | -- | -- | -- | $179.8M | $210.5M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $354.7M | $617.8M | -$426.1M | -$150.8M | $374.5M | |
Capital Expenditures | $308.8M | $515.7M | $425.3M | $435M | $393.4M | |
Cash Acquisitions | -$10.2M | -- | -$333.7M | -$16.6M | -- | |
Cash From Investing | $112.7M | -$491.7M | $23.6M | $530.2M | $278.9M | |
Dividends Paid (Ex Special Dividend) | -$177.5M | -$132.5M | -$204.6M | -$201M | -$216.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $527.3M | -- | -- | |
Long-Term Debt Repaid | -$73.7M | -$80.9M | -$227.4M | -$508.8M | -$99.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $148M | $599.3M | -$12.3M | -$349.9M | -$11.8M | |
Cash From Financing | -$141.2M | $707.2M | -$34.2M | -$1.2B | -$443.4M | |
Beginning Cash (CF) | $1.6B | $2.1B | $2.9B | $2.5B | $1.7B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $326.2M | $833.3M | -$436.7M | -$812.3M | $210.1M | |
Ending Cash (CF) | $2B | $2.9B | $2.4B | $1.7B | $1.9B | |
Levered Free Cash Flow | $46M | $102.1M | -$851.4M | -$585.8M | -$18.9M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.